Urinary extracellular vesicles (uEVs) are regarded as highly promising liquid-biopsy
biomarkers for the early diagnosis and prognosis of bladder cancer (BC). However …

Bladder cancer (BC) is the 10th most frequently diagnosed cancer worldwide. Although
urine cytology and cystoscopy are current standards for BC diagnosis, both have limited …

Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology.
Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is …

Simple Summary The diagnostic and monitoring techniques used for urologic cancers
comprise a group of invasive methodologies that still lack sensitivity and specificity …

Proteomic analysis of urinary extracellular vesicles (EVs) is a powerful approach to discover
potential bladder cancer (BCa) biomarkers, however urine contains numerous EVs derived …

Objective Urinary extracellular vesicles (EV) could be promising biomarkers for urological
diseases. In this retrospective feasibility study, we conducted biomarker screening for early …

Extracellular vesicles (EVs), including exosomes and microvesicles, are present in a variety
of bodily fluids, and the concentration of these sub-cellular vesicles and their associated …

Extracellular vesicles (EVs) contain a variety of biomolecules and provide information about
the cells that produce them. EVs from cancer cells found in urine can be used as biomarkers …

Clinically, the detection of bladder cancer (BCa) typically requires cystoscopy, which is
potentially harmful and sometimes accompanied by adverse effects. Thus, new biomarkers …

Extracellular vesicles (EVs) are present in a variety of bodily fluids and they play an
important role in cellular communications and signal transduction mechanisms. Studies …